Please assess the completion status of the following clinical trial:

Trial Title: Thiamin Against Robust IBD Fatigue

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inflammatory Bowel Disease~* Disease in remission~* Chronic fatigue~Exclusion Criteria:~* Co-morbidity that can explain fatigue~* Pregnancy~* Non-compliance to the study procedures~* Possible surgery in the study period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Thiamin (Type: ACTIVE_COMPARATOR): Oral thiamine: 600 - 1800 mg/day in 4 weeks. Dose is depending on gender and age. Tablet contains 300 mg Thiamine each.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo: same number of tablets as in the active comparator arm, in 4 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).